Ethics Approval Granted For Tissue Therapeutics 's VitroGro Human Clinical Trial  
2/7/2008 3:07:21 PM

Brisbane, Feb 7, 2008 (ABN Newswire) - Biomedical company, Tissue Therapies Limited (ASX: TIS) today announced that formal approval has been received from the Trafalgar Ethics Board in Toronto to proceed with the human clinical trial of VitroGro for the treatment of diabetic and venous ulcers scheduled to begin later this month.